RxDoctor Payments Data

Innjea Park, DPM

Foot & Ankle Surgery · Staten Island, NYNPI 1174907992

Payments from drug & device makers

$11,137in general payments, 2019–2025

Across 113 payments — averaging $98.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Osteomed LLC$5K
  • Stryker$2K
  • Acumed LLC$1K
  • Gotham Surgical Solutions & Devices, Inc.$990
  • Advanced Oxygen Therapy Inc.$337
  • Kerecis Limited$292
  • plus $820 from 15 others

What the payments were for

  • Speaking & faculty fees$5,00045%
  • Travel & lodging$440%
  • Food & beverage$5,11046%
  • Education$9839%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,137 in reported general payments places this provider in the 80th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$147,771
Medicare patients
160
Services billed
609

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tavaborole225$92,516
Diclofenac Sodium318$85,558
JubliaEfinaconazole30$44,071
Diclofenac Epolamine46$27,911
Ciclopirox185$8,382
Oxiconazole Nitrate13$6,575
Diflorasone Diacetate14$5,436
Ketoconazole110$2,618
Ammonium Lactate240$2,528
Clotrimazole78$2,323
Doxepin Hcl19$2,284
Fluocinonide13$875
CiclopiroxCiclopirox Olamine14$622
Mupirocin33$261
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$159

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$15$44,07130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 652 foot & ankle surgery providers in New York.

Other foot & ankle surgery in Staten Island

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →